Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2023, 32(2):92-102

Lyme carditis - one face of Lyme borreliosis

Dúbrava M1, Koščálová A2, Jánošiová J1
1 I. klinika geriatrie LF UK a UN, Bratislava
2 Klinika infektológie a geografickej medicíny LF SZU a UN, Bratislava, Slovenská republika

Lyme borreliosis (LB) belongs to clinically significant anthropozoonoses. It is caused by spirochetes of the genus Borrelia, which is transmitted to humans by a tick. Due to climate change, we must expect that LB will occur even more often than before in our country as well. The leading clinical manifestation of LB is self-limiting erythema migrans. However, after dissemination of the pathogen from the skin to various tissues, LB becomes a systemic disease and can manifest as a target organ disease that has the potential to significantly reduce the quality of life. Such organ localizations also include the heart, although rarely. Lyme carditis (LC) can not be isolated from LB. In this text we summarize general information about LB and offer an overview of existing knowledge about LC.

Keywords: Lyme borreliosis; Lyme carditis

Published: February 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dúbrava M, Koščálová A, Jánošiová J. Lyme carditis - one face of Lyme borreliosis. Cardiology Letters. 2023;32(2):92-102.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Holečková K, Koščálová A, Schréter I. Štandardné postupy: Lymská borelióza. https://www.health.gov.sk/?Standardne-PostupyV-Zdravotnictve, 2021.
    2. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Neurology 2021;96:262-273. Go to original source...
    3. Figoni J, Chirouze C, Hansmann Y, et al. Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis. Med Mal Infect 2019;49:318-334. Go to original source...
    4. National Guideline Centre (UK). Evidence review for the management of Lyme carditis: Lyme disease: diagnosis and management: Evidence review I. London: National Institute for Health and Care Excellence (NICE); 2018 Apr. PMID: 35201690.
    5. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet 2012;379:461-473. Go to original source...
    6. Marques AR, Strle F, Wormser GP. Comparison of Lyme Disease in the United States and Europe. Emerg Infect Dis 2021;27:20172024. Go to original source...
    7. Bouchard C, Leonard E, Koffi JK, et al. The increasing risk of Lyme disease in Canada. Can Vet J 2015;56:693-699.
    8. Kříž B, Fialová A, Šebestová H, Daniel M, Malý M. Comparison of the epidemiological patterns of Lyme borreliosis and tick-borne encephalitis in the Czech Republic in 2007-2016. Epidemiol Mikrobiol Imunol 2018;67:134-140.
    9. Petrulionienė A, Radzišauskienė D, Ambrozaitis A, et al. Epidemiology of Lyme Disease in a Highly Endemic European Zone. Medicina (Kaunas) 2020;56:115. Go to original source...
    10. Sajanti E, Virtanen M, Helve O, et al. Lyme Borreliosis in Finland, 1995-2014. Emerg Infect Dis. 2017;23:1282-1288. Go to original source...
    11. Bacon RM, Kugeler KJ, Mead PS; Centers for Disease Control and Prevention (CDC). Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill Summ 2008;57:1-9.
    12. Dantas-Torres F. Climate change, biodiversity, ticks and tick-borne diseases: The butterfly effect. Int J Parasitol Parasites Wildl 2015;: 452-461. Go to original source...
    13. Gray JS, Dautel H, Estrada-Peña A, Kahl O, Lindgren E. Effects of climate change on ticks and tick-borne diseases in europe. Interdiscip Perspect Infect Dis 2009;593232. Go to original source...
    14. Strnad M, Hönig V, Růžek D, Grubhoffer L, Rego ROM. EuropeWide Meta-Analysis of Borrelia burgdorferi Sensu Lato Prevalence in Questing Ixodes ricinus Ticks. Appl Environ Microbiol 2017;83:e00609-17 Go to original source...
    15. Stepánová-Tresová G, Pet'ko B, Stefancíková A, Nadzamová D. Occurrence of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii in the Ixodes ricinus ticks from Eastern Slovakia. Eur J Epidemiol 2000;16:105-109. Go to original source...
    16. Chvostáč M, Špitalská E, Václav R, Vaculová T, Minichová L, Derdáková M. Seasonal Patterns in the Prevalence and Diversity of Tick-Borne Borrelia burgdorferi Sensu Lato, Anaplasma phagocytophilum and Rickettsia spp. in an Urban Temperate Forest in South Western Slovakia. Int J Environ Res Public Health 2018;15:994. Go to original source...
    17. EPIS. 2022. Epidemiologický informačný systém. Výročné správy. http://www.epis.sk/InformacnaCast/Publikacie/VyrocneSpravy.aspx.
    18. Trevisan G, Cinco M, Trevisini Sn, et al. Borreliae Part 1: Borrelia Lyme Group and Echidna-Reptile Group. Biology (Basel) 2021;10:1036. Go to original source...
    19. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17. Go to original source...
    20. Dammin GJ. Erythema migrans: a chronicle. Rev Infect Dis 1989;11:142-151. Go to original source...
    21. Steere AC, Broderick TF, Malawista SE. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol 1978;108:312-321. Go to original source...
    22. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease - a tick-borne spirochetosis? Science 1982;216:1317-1319. Go to original source...
    23. Coburn J, Garcia B, Hu LT et al. Lyme Disease Pathogenesis. Curr Issues Mol Biol 2021; 42: 473 - 518. Go to original source...
    24. Hyde JA. Borrelia burgdorferi Keeps Moving and Carries on: A Review of Borrelial Dissemination and Invasion. Front Immunol 2017;8:114. Go to original source...
    25. Beneš J (Ed.). Infekční lékařství. Praha: Galen; 2009:651 s.
    26. Cook MJ. Lyme borreliosis: a review of data on transmission time after tick attachment. Int J Gen Med 2014;8:1-8. Go to original source...
    27. Aberer E. What should one do in case of a tick bite? Curr Probl Dermatol 2009; 37: 155 - 166. Go to original source...
    28. Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nat Rev Dis Primers 2016;2:16090. Go to original source...
    29. Steere AC. Lyme disease. N Engl J Med. 2001;345:115-125. Go to original source...
    30. Cadavid D, Bai Y, Hodzic E, Narayan K, Barthold SW, Pachner AR. Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi. Lab Invest 2004;84:1439-1450. Go to original source...
    31. Raveche ES, Schutzer SE, Fernandes H, et al. Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis. J Clin Microbiol 2005;43:850-856. Go to original source...
    32. Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for lyme disease. Clin Infect Dis 2008;47:188-195. Go to original source...
    33. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003;187:1187-1199. Go to original source...
    34. Nowalk AJ, Gilmore RD Jr, Carroll JA. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect Immun 2006;74:3864-3873. Go to original source...
    35. Kurtenbach K, De Michelis S, Etti S, et al. Host association of Borrelia burgdorferi sensu lato - the key role of host complement. Trends Microbiol 2002; 10:74-79. Go to original source...
    36. Iyer R, Caimano MJ, Luthra A, et al. Stage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation. Mol Microbiol 2015;95:509-538. Go to original source...
    37. Steere AC, Sikand VK, Schoen RT, Nowakowski J. Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis 2003;37:528532. Go to original source...
    38. Vorou RM, Papavassiliou VG, Tsiodras S. Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiol Infect 2007;135:1231-1247. Go to original source...
    39. Berglund J, Eitrem R, Ornstein K, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995;333:1319-1327. Go to original source...
    40. Huppertz HI, Böhme M, Standaert SM, Karch H, Plotkin SA. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999;18:697-703. Go to original source...
    41. Radesich C, Del Mestre E, Medo K, et al. Lyme Carditis: From Pathophysiology to Clinical Management. Pathogens. 2022;11:582. Go to original source...
    42. Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med 2006; 354:2794-2801. Go to original source...
    43. Strle F, Nadelman RB, Cimperman J, et al. Comparison of cultureconfirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999;130:32-36. Go to original source...
    44. Strle F, Ružić-Sabljić E, Logar M, et al. Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis 2011;11:1253,1258. Go to original source...
    45. Nadelman RB, Nowakowski J, Forseter G, et al. The clinical spectrum of early Lyme borreliosis in patients with cultureconfirmed erythema migrans. Am J Med 1996;100:502-508. Go to original source...
    46. Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med 2003;348:2472-2474. Go to original source...
    47. Burlina PM, Joshi NJ, Mathew PA, Paul W, Rebman AW, Aucott JN. AI-based detection of erythema migrans and disambiguation against other skin lesions. Comput Biol Med 2020;125:103977. Go to original source...
    48. Oksi J, Marttila H, Soini H, Aho H, Uksila J, Viljanen MK. Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS 2001;109:581-588. Go to original source...
    49. Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosisepidemiology, diagnosis and management. Nat Rev Neurol. 2015;11:446-456. Go to original source...
    50. Marques AR. Lyme Neuroborreliosis. Continuum (Minneap Minn) 2015;21(6 Neuroinfectious Disease):1729-1744. Go to original source...
    51. Rauer S, Kastenbauer S, Fingerle V, Hunfeld KP, Huppertz HI, Dersch R. Lyme Neuroborreliosis. Dtsch Arztebl Int 2018;115:751-756. Go to original source...
    52. Dersch R, Rauer S. Neuroborreliose - Diagnostik, Therapie und Verlauf. Nervenarzt 2017;88:419-431. Go to original source...
    53. Halperin JJ. Nervous system Lyme disease, chronic Lyme disease, and none of the above. Acta Neurol Belg 2016;116:1-6. Go to original source...
    54. Balcer LJ, Winterkorn JM, Galetta SL. Neuro-ophthalmic manifestations of Lyme disease. J Neuroophthalmol 1997;17:108-121. Go to original source...
    55. Kaminsky AL, Maisonobe T, Lenglet T, Psimaras D, Debs R, Viala K. Confirmed cases of Neuroborreliosis with involvement of peripheral nervous system: Description of a cohort. Medicine (Baltimore). 2020;99:e21986. Go to original source...
    56. Oschmann P, Dorndorf W, Hornig C, Schäfer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol 1998;245:262-272. Go to original source...
    57. Back T, Grünig S, Winter Y, et al. Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life. J Neurol 2013;260:1569-1575. Go to original source...
    58. Nemeth J, Bernasconi E, Heininger U, et al. for The Swiss Society For Infectious Diseases And The Swiss Society For Neurology. Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med Wkly 2016;146:w14353. Go to original source...
    59. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther 2014;12:11031135. Go to original source...
    60. Shapiro ED, Wormser GP. Lyme Disease in 2018: What Is New (and What Is Not). JAMA 2018;320:635-636. Go to original source...
    61. Wilske B. Diagnosis of lyme borreliosis in Europe. Vector Borne Zoonotic Dis 2003;3:215-227. Go to original source...
    62. Glatz M, Golestani M, Kerl H, Müllegger RR. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Arch Dermatol 2006;142:862-868. Go to original source...
    63. Markowicz M, Reiter M, Gamper J, Stanek G, Stockinger H. Persistent Anti-Borrelia IgM Antibodies without Lyme Borreliosis in the Clinical and Immunological Context. Microbiol Spectr 2021;9:e0102021. Go to original source...
    64. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis 2001;33:780-785. Go to original source...
    65. Rauer S, Kastenbauer S, Hofmann H, et al. Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis. Ger Med Sci 2020;18: Doc03.
    66. Harms MG, Hofhuis A, Sprong H, et al. A single dose of doxycycline after an ixodes ricinus tick bite to prevent Lyme borreliosis: An open-label randomized controlled trial. J Infect 2021;82:98-104. Go to original source...
    67. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with singledose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79-84. Go to original source...
    68. Dattwyler RJ, Gomes-Solecki M. The year that shaped the outcome of the OspA vaccine for human Lyme disease. NPJ Vaccines 2022;7:10. Go to original source...
    69. Sajid A, Matias J, Arora G et al. mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent. Sci Transl Med 2021;13:eabj9827. Go to original source...
    70. Stanek G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011;17:69-79. Go to original source...
    71. Steere AC, Batsford WP, Weinberg M, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 1980;93:8-16. Go to original source...
    72. Fish AE, Pride YB, Pinto DS. Lyme carditis. Infect Dis Clin North Am 2008; 22:275-288. Go to original source...
    73. European Union. Regulation (EC) N°141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. 2000. http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:EN:PDF.
    74. Lewandrowski EL, Lewandrowski K. Measurement of High Sensitivity Troponin T in Patients with Early Stage Lyme Disease: Preliminary Evidence for Possible Subclinical Cardiac Involvement. Ann Clin Lab Sci 2022;52:179-184.
    75. Van der Linde MR. Lyme carditis: clinical characteristics of 105 cases. Scand J Infect Dis 1991;77(Suppl):81-84.
    76. Forrester JD, Mead P. Third-degree heart block associated with lyme carditis: review of published cases. Clin Infect Dis 2014;59:996-1000. Go to original source...
    77. Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme Disease - United States, 2008-2015. MMWR Surveill Summ 2017;66:1-12. Go to original source...
    78. Sharma AK, Almaddah N, Chaudhry K, Ganatra S, Chaudhry GM, Silver J. Without Further Delay: Lyme Carditis. Am J Med 2018;131:384-386. Go to original source...
    79. Robinson ML, Kobayashi T, Higgins Y, Calkins H, Melia MT. Lyme carditis. Infect Dis Clin North Am 2015;29:255-268. Go to original source...
    80. Pinto DS. Cardiac manifestations of Lyme disease. Med Clin North Am 2002;86:285-296. Go to original source...
    81. Krause PJ, Bockenstedt LK. Cardiology patient pages. Lyme disease and the heart. Circulation 2013;127:e451-e454. Go to original source...
    82. Besant G, Wan D, Yeung C, et al. Suspicious index in Lyme carditis: Systematic review and proposed new risk score. Clin Cardiol 2018;41:1611-1616. Go to original source...
    83. Patel KP, Farjo PD, Juskowich JJ, Hama Amin A, Mills JD. Earlyonset Lyme carditis with concurrent disseminated erythema migrans. Am J Cardiovasc Dis 2017;7:53-56.
    84. Yeung C, Baranchuk A. Diagnosis and Treatment of Lyme Carditis: JACC Review Topic of the Week. J Am Coll Cardiol 2019;73:717-726. Go to original source...
    85. Cunha BA, Elyasi M, Singh P, Jimada I. Lyme carditis with isolated left bundle branch block and myocarditis successfully treated with oral doxycycline. IDCases 2017;11:48-50. Go to original source...
    86. Cheung B, Lutwick L, Cheung M. Possible Lyme Carditis with Sick Sinus Syndrome. IDCases. 2020;20 e00761. Go to original source...
    87. Szymanska A, Platek AE, Dluzniewski M, Szymanski FM. History of Lyme Disease as a Predictor of Atrial Fibrillation. Am J Cardiol 2020;125:1651-1654. Go to original source...
    88. Luli J, Saccoh I, Johnson E, Fu E, Nelson S, Amin A. Lyme disease: A cause of polymorphic ventricular tachycardia. HeartRhythm Case Rep 2020;6:930-932. Go to original source...
    89. Beach CM, Stewart E, Marcuccio E, Beerman L, Arora G. Lyme carditis presenting as paroxysmal junctional tachycardia and complete atrioventricular block in an adolescent. J Electrocardiol 2023;76:14-16. Go to original source...
    90. Rudenko N, Golovchenko M, Mokracek A, et al. Detection of Borrelia bissettii in cardiac valve tissue of a patient with endocarditis and aortic valve stenosis in the Czech republic. J Clin Microbiol 2008;46:3540-3543. Go to original source...
    91. Fatima B, Sohail MR, Schaff HV. Lyme Disease - An Unusual Cause of a Mitral Valve Endocarditis. Mayo Clin Proc Innov Qual Outcomes 2018;2:398-401. Go to original source...
    92. Canver CC, Chanda J, DeBellis D, et al. Possible relationship between degenerative cardiac valvular pathology and lyme disease. Ann Thorac Surg 2000;70:283-285. Go to original source...
    93. Nikolić A, Boljević D, Bojić M, et al. Lyme Endocarditis as an Emerging Infectious Disease: A Review of the Literature. Front Microbiol 2020;11:278. Go to original source...
    94. Malik MB, Baluch A, Adhikari S, Quraeshi S, Rao S. Early Onset Lyme Myopericarditis With Left Ventricular Dysfunction and Mitral Regurgitation. J Investig Med High Impact Case Rep 2021;9:23247096211045267. Go to original source...
    95. Muehlenbachs A, Bollweg BC, Schulz TJ, et al. Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis. Am J Pathol 2016;186:1195-1205. Go to original source...
    96. Eckenrode K. Early identification of Lyme disease complications. JAAPA 2023;36:19-23. Go to original source...
    97. Wang CN, Yeung C, Enriquez A, et al. Long-term Outcomes in Treated Lyme Carditis. Curr Probl Cardiol 2022;47:100939. Go to original source...
    98. Yoon EC, Vail E, Kleinman G, et al. Lyme disease: a case report of a 17-year-old male with fatal Lyme carditis. Cardiovasc Pathol 2015;24:317-321. Go to original source...
    99. Motamed M, Liblik K, Miranda-Arboleda AF, et al. Lyme disease and dilated cardiomyopathy: A systematic review. Trends Cardiovasc Med 2022; S10501738(22:00077-9.
    100. Moore A, Nelson C, Molins C, Mead P, Schriefer M. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States. Emerg Infect Dis 2016;22:1169-1177. Go to original source...
    101. Michalski B, Umpierrez De Reguero A. Lyme Carditis Buried Beneath ST-Segment Elevations. Case Rep Cardiol 2017;2017:9157625. Go to original source...
    102. Horowitz HW, Belkin RN. Acute myopericarditis resulting from Lyme disease. Am Heart J 1995;130:176-178. Go to original source...
    103. Župan Ž, Mijatović D, Medved I et al. Successful treatment of fulminant Lyme myocarditis with mechanical circulatory support in a young male adult: a case report. Croat Med J 2017;58:185-193. Go to original source...
    104. Maher B, Murday D, Harden SP. Cardiac MRI of Lyme disease myocarditis. Heart 2012;98:264. Go to original source...
    105. Avitabile CM, Harris MA, Chowdhury D. Cardiac Magnetic Resonance Characterizes Myocarditis in a 16-Year-Old Female With Lyme Disease. World J Pediatr Congenit Heart Surg 2016;7:394-396. Go to original source...
    106. Kubánek M, Šramko M, Berenová D, et al. Detection of Borrelia burgdorferi sensu lato in endomyocardial biopsy specimens in individuals with recent-onset dilated cardiomyopathy. Eur J Heart Fail 2012;14:588-596. Go to original source...
    107. Kaczmarek KA, Szwabe K, Urbanek I, et al. Prevalence of Lyme Carditis in Patients with Atrioventricular Blocks. Int J Environ Res Public Health 2022;19: 14893. Go to original source...
    108. Lyme carditis. https://www.cdc.gov/lyme/treatment/lymecarditis.html
    109. Wan D, Blakely C, Branscombe P, Suarez-Fuster L, Glover B, Baranchuk A. Lyme Carditis and High-Degree Atrioventricular Block. Am J Cardiol 2018;121:1102-1104. Go to original source...
    110. Uzomah UA, Rozen G, Mohammadreza Hosseini S, et al. Incidence of carditis and predictors of pacemaker implantation in patients hospitalized with Lyme disease. PLoS One 2021;16:e0259123. Go to original source...

    Return to the content